Methyldopa Stada (Methyldopa)

Methyldopa is converted in the body to alpha‑methylnorepinephrine, which activates central alpha‑2 adrenergic receptors. This activation reduces the release of norepinephrine, decreasing sympathetic nervous system activity, which in turn lowers peripheral vascular resistance and blood pressure.

The dosage of Methyldopa Stada is individualized by the prescribing clinician based on the patient’s blood‑pressure goals, age, renal function and other clinical factors. The prescriber determines the appropriate starting dose and any subsequent titration.

Methyldopa is one of the few antihypertensives that has been used in pregnancy under medical supervision. While it may be prescribed for gestational hypertension, safety data are limited, and the decision should be made by a qualified healthcare professional. Information on breastfeeding is also limited, so a clinician should assess risks and benefits.

To request Methyldopa Stada, submit an enquiry on the product page at gnhindia.com specifying the required quantity. GNH India works with hospitals, pharmacies and procurement teams worldwide, verifies trade or institutional credentials, and then provides pricing, availability, shipping details and any required import documentation.

Methyldopa differs from many newer agents because it acts centrally on alpha‑2 receptors, whereas drugs like ACE inhibitors or calcium‑channel blockers target peripheral pathways. It is often chosen for pregnant patients because of its longer safety record, but it may cause more sedation and hematologic effects than some alternatives.

Methyldopa Stada should be stored at room temperature, below 25 °C, in its original packaging. Keep the product away from moisture, heat and direct sunlight to maintain stability and potency.

Methyldopa Stada is taken orally, usually with a glass of water. It can be taken with or without food, but consistency with meals may help reduce gastrointestinal discomfort. The exact dosing schedule is set by the prescriber.

Serious adverse reactions include severe anemia or hemolytic anemia, liver dysfunction, lupus‑like syndrome, agranulocytosis and profound hypotension. Patients should be monitored for signs of these conditions, and any sudden or severe symptoms should prompt immediate medical evaluation.

Methyldopa Stada is contraindicated in individuals with known hypersensitivity to methyldopa or any of its excipients. Caution is also advised for patients with severe liver disease, certain blood disorders, or those taking interacting medications such as MAO inhibitors or clonidine without close supervision.